Gear Up for Ecolab (ECL) Q1 Earnings: Wall Street Estimates for Key Metrics

Core Viewpoint - Analysts project Ecolab (ECL) will report quarterly earnings of $1.51 per share, a 12.7% increase year over year, with revenues expected to reach $3.7 billion, reflecting a 1.4% decline from the same quarter last year [1]. Earnings Estimates - There has been a 0.2% upward revision in the consensus EPS estimate over the last 30 days, indicating analysts' reassessment of their initial forecasts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are strongly linked to short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Sales- Global Healthcare and Life Sciences (Fixed Currency rates)' will be $254.92 million, down 33.4% year over year [5]. - 'Sales- Global Industrial (Public Currency rates)' is projected to reach $1.84 billion, showing a slight increase of 0.3% from the previous year [5]. - 'Sales- Global Institutional & Specialty (Public Currency rates)' is expected to be $1.29 billion, reflecting a year-over-year increase of 1.8% [6]. - 'Sales- Global Institutional & Specialty (Fixed Currency rates)' is estimated at $1.37 billion, indicating a 7.9% increase from the same quarter last year [6]. - 'Sales- Global Industrial (Fixed Currency rates)' is forecasted to be $1.92 billion, representing a 4.1% year-over-year increase [6]. Operating Income Estimates - 'Operating Income- Global Industrial (Fixed Currency rates)' is projected to be $302.98 million, up from $265 million in the same quarter last year [7]. - 'Operating Income- Global Institutional & Specialty (Fixed Currency rates)' is expected to reach $279.46 million, compared to $248 million reported in the same quarter last year [8]. - 'Operating Income- Global Healthcare and Life Sciences (Fixed Currency rates)' is estimated at $30.71 million, down from $37 million year over year [8]. - 'Operating Income- Global Institutional & Specialty (Public Currency rates)' is projected to be $283.10 million, compared to $247 million in the same quarter last year [9]. - 'Operating Income- Global Healthcare & Life Sciences (Public Currency rates)' is expected to be $32.69 million, down from $36.30 million year over year [9]. - The consensus estimate for 'Operating Income- Global Industrial (Public Currency rates)' stands at $300.55 million, compared to $265.40 million in the previous year [10]. Stock Performance - Ecolab shares have returned -5.7% over the past month, compared to a -5.1% change in the Zacks S&P 500 composite [11].